StockClub

GALT

GALTGalectin Therapeutics Inc.$ --
Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

GALT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M USD
YoY -
Operating Income
-4M USD
YoY +53.7%
Net Income
-8M USD
YoY +27.1%
EPS
-0.13$
YoY +27.8%

Revenue

$0
FY2023 Q4$0
$0
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
Actual
$0 (-)

Net Income

$-25.3M
FY2023 Q4$-41.1M
$-41.1M
Q4
FY2024 Q1$-11.5M
$-11.5M
Q1
FY2024 Q2$-23.9M
$-23.9M
Q2
FY2024 Q3$-35.1M
$-35.1M
Q3
FY2024 Q4$-47M
$-47M
Q4
FY2025 Q1$-9.6M
$-9.6M
Q1
FY2025 Q2$-17.2M
$-17.2M
Q2
FY2025 Q3$-25.3M
$-25.3M
Q3
Actual
+$9.7M (+27.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$0
FY2019
$0
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023MISS
Actual:$0
Est:$64.7M
FY2023MISS
$0
FY2024MISS
Actual:$0
Est:$208M
FY2024MISS
$0

Analyst Estimates